Loading clinical trials...
Loading clinical trials...
Validating the Use of Radar Micro-Doppler Characteristics for Accurate Prediction of Human Movement
The analysis of human motion using radar has become an increasingly active topic of study due to the diverse applications offered by such an analysis (Lai et al., 2008; Fairchild \& Narayanan, 2016; Narayanan et al., 2014). Information about human motion has important applications for urban military operations, search-and-rescue missions, surveillance, and hospital patient monitoring. The micro-motions of human movement in the presence of radar illumination creates unique modulations in the received signal known as the micro-Doppler effect. By analyzing these frequency modulations, one can infer the type of movement being performed. This micro-motion associated with human movement produces a nonlinear and non-stationary signal that can be characterized using time-frequency domain analysis. Such signals will be used to identify high injury risk versus low injury risk athletes, which creates an opportunity to direct limited prevention resources to these high-risk athletes; identify individuals at risk of falls; and, may even be useful in diagnosing conditions such as Parkinson's where asymmetrical movement patterns occur as an early indicator. Traditional methods of movement analysis involve the use of expensive video motion capture systems that accurately measure the 3-dimensional position of passive reflective markers affixed to human body landmarks such as joints and body segments, and while motion capture systems are used to effectively estimate movement dynamics, they are generally not portable, they are expensive, and they can be cumbersome when the reflective markers are applied to older persons or persons with movement deficiencies. Drs. Narayanan and Onks have successfully tested a novel use of Doppler radar that is portable, less expensive, and eliminates the need for affixing cumbersome reflective markers to participants. In addition, preliminary testing has demonstrated the ability to discriminate between certain movement conditions at a level of precision we feel are not obtainable with video motion capture.
Each subject will report for their scheduled data collection in the biomechanics laboratory. Boney landmarks (shoulder, hip, knee, ankle, etc.) will be used to place small reflective markers for use with motion capture analysis. The radar will be positioned so that the MDS data can be captured simultaneously with the motion capture data. Each volunteer will complete the following activities: • Walk with athletic shoes * Walk with bilateral heel lifts in shoes * Walk with unilateral heel lift * Squat jump with athletic shoes * Squat jump with bilateral heel lifts in shoes * Squat Jump with unilateral heel lift * Stationary standing posture with athletic shoes * Stationary standing posture with bilateral heel lifts in shoes * Stationary standing posture with unilateral heel lift Each activity will be performed three times toward the radar in order to assess repeatability and reliability, and also for maintaining adequate statistical training and testing datasets for confirming the use of previous established classification algorithms. These algorithms will again be used to calculate prediction accuracy for the different activities (walking, jumping, and stationary posture) and different footwear conditions (shoes without inserts, shoes with bilateral inserts, shoes with unilateral inserts). The biomechanical motion capture data will be processed similarly to the MDS data to compare to accuracy between the two methods for the same observed task-specific differences. Our goal is to determine if MDS can achieve the same measurement accuracy as motion capture for the same task. Since biomechanical motion capture is the "gold standard" of human movement measurement, the successful completion of this aim will establish the validity of MDS as an effective clinical measure of human movement.
Age
18 - 25 years
Sex
ALL
Healthy Volunteers
Yes
Start Date
July 1, 2021
Primary Completion Date
January 1, 2022
Completion Date
January 1, 2022
Last Updated
November 10, 2021
Lead Sponsor
Milton S. Hershey Medical Center
NCT07327463
NCT07432711
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions